Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 14, 2023

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2029

Conditions
Alzheimer's Disease
Interventions
DRUG

AV-1451

This is a cross-sectional study using the radiotracer AV-1451 to determine the relationship of tau pathology to other biomarker data of MPC participants.

Trial Locations (2)

19104

RECRUITING

University of Pennsylvania, Philadelphia

02114-2696

RECRUITING

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Massachusetts General Hospital

OTHER

lead

University of Pennsylvania

OTHER